Projects per year
Search results
-
Active
Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene autoleucel (cilta-cel) Out-of-Specification (OOS) in patients with Multiple Myeloma
Ganguly, S. (PI), Heslop, H. (Key Personnel), Mai, H. P. (Key Personnel), Pingali, S. R. (Key Personnel) & Shah, S. (Key Personnel)
1/28/25 → …
Project: Clinical Trial
-
A Phase 1/2, First-in-Human Study of the Menin-KMT2A (MLL1) Inhibitor Bleximenib in Participants With Acute Leukemia
Shah, S. (PI), Ganguly, S. (Key Personnel), Guan, J. (Key Personnel), Mai, H. P. (Key Personnel) & Pingali, S. R. (Key Personnel)
10/25/24 → …
Project: Clinical Trial
-
Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) with Carfilzomib Based Therapy in Plasma Cell Myeloma Patients Refractory to Carfilzomib
Pingali, S. R. (PI), Ganguly, S. (Key Personnel), Guan, J. (Key Personnel), Mai, H. P. (Key Personnel), Mathur, S. (Key Personnel), Shah, S. (Key Personnel) & Yi, Q. (Key Personnel)
7/29/24 → …
Project: Clinical Trial
-
IMPACT ON SURVIVAL OF FAITH-BASED SPIRITUAL CARE OR PSYCHOTHERAPY COMBINED WITH PALLIATIVE CARE VERSUS PALLIATIVE CARE ALONE IN PATIENTS WITH NON-CURATIVE MALIGNANCIES
Mai, H. P. (PI), Abdelrahim, M. (Key Personnel), Ganguly, S. (Key Personnel), Guan, J. (Key Personnel), Heyne, K. (Key Personnel), Mathur, S. (Key Personnel), Niravath, P. A. (Key Personnel), Pingali, S. R. (Key Personnel), Puri, A. (Key Personnel), Shah, S. (Key Personnel), Singh, M. (Key Personnel), Sun, K. (Key Personnel), Venta, L. A. (Key Personnel) & Zhang, J. (Key Personnel)
6/19/24 → …
Project: Clinical Trial
-
Open-Label, Multicenter, Phase 1 Study to Assess the Safety of P-BCMA-ALLO1 in Subjects with Relapsed / Refractory Multiple Myeloma (MM)
Ganguly, S. (PI), Mai, H. P. (Key Personnel), Pingali, S. R. (Key Personnel) & Shah, S. (Key Personnel)
3/21/24 → …
Project: Clinical Trial
-
Fulvestrant Plus Abemaciclib With or Without Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer
Niravath, P. A. (PI), Guan, J. (Key Personnel), Heyne, K. (Key Personnel), Mai, H. P. (Key Personnel), Mathur, S. (Key Personnel), Puri, A. (Key Personnel) & Sun, K. (Key Personnel)
7/15/21 → …
Project: Clinical Trial
-
A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY OF TRASTUZUMAB DERUXTECAN (T-DXd) VERSUS TRASTUZUMAB EMTANSINE (T-DM1) IN SUBJECTS WITH HIGH-RISK HER2-POSITIVE PRIMARY BREAST CANCER WHO HAVE RESIDUAL INVASIVE DISEASE IN BREAST OR
Mai, H. P. (PI)
7/6/21 → 7/5/31
Project: Non Profit
-
ALLIANCE A221602: OLANZAPINEWITH ORWITHOUT FOSAPREPITANT FOR THE PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY (HEC): A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Darcourt, J. (PI), Mai, H. P. (PI), Bernicker, E. H. (CoI), Chang, J. C. (CoI), Geyer, C. E. (CoI), Heyne, K. (CoI) & Niravath, P. A. (CoI)
3/6/20 → 3/5/45
Project: Non Profit